There were 926 press releases posted in the last 24 hours and 442,545 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Merck's Investigational Allergy Immunotherapy Tablet (AIT) Significantly Reduced the Combination of Ragweed Allergy Symptoms and Medication Use in Phase III Trial

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image